BIO-key International (BKYI) to Release Earnings on Monday

BIO-key International (NASDAQ:BKYIGet Rating) is scheduled to announce its earnings results before the market opens on Monday, May 16th. BIO-key International has set its FY 2022 guidance at EPS.

BIO-key International (NASDAQ:BKYIGet Rating) last issued its quarterly earnings data on Tuesday, March 29th. The technology company reported ($0.26) earnings per share (EPS) for the quarter. BIO-key International had a negative net margin of 96.70% and a negative return on equity of 27.76%. The company had revenue of $0.94 million during the quarter.

Shares of NASDAQ:BKYI traded down $0.01 on Wednesday, hitting $2.08. The company had a trading volume of 10,596 shares, compared to its average volume of 71,736. BIO-key International has a 52-week low of $1.90 and a 52-week high of $4.28. The business has a 50 day moving average of $2.25 and a 200 day moving average of $2.36. The company has a market cap of $17.48 million, a PE ratio of -3.30 and a beta of 0.86.

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC grew its position in shares of BIO-key International, Inc. (NASDAQ:BKYIGet Rating) by 33.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 85,219 shares of the technology company’s stock after acquiring an additional 21,282 shares during the quarter. Geode Capital Management LLC owned about 1.09% of BIO-key International worth $186,000 at the end of the most recent quarter. 6.92% of the stock is owned by institutional investors.

BIO-key International Company Profile (Get Rating)

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

Featured Stories

Earnings History for BIO-key International (NASDAQ:BKYI)

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with's FREE daily email newsletter.